BioCare SD

What BioCare SD does

BioCare SD is a national specialty pharmaceutical distributor and a subsidiary of BioCare, Inc. (founded 1982), headquartered in Tempe, Arizona, with a second NABP-accredited distribution facility in Olive Branch, Mississippi. The company distributes specialty therapeutics across two primary verticals — oncology and retina — to independent community-based healthcare practices, with a stated 40+ year heritage in specialty distribution. Its product portfolio spans retina and oncology specialty pharmaceuticals, supported by a self-service e-commerce storefront (store.biocaresd.com) for existing customers.

The company operates a technology-enabled distribution platform that integrates with partner systems, most notably the WeInfuse infusion management platform (reaching 1,300+ provider locations) and the AllyGPO group purchasing organization, whose AllyIQ drug management platform provides AI-powered drug management, real-time product availability visibility, and workflow optimization. BioCareSD markets a 'high-touch' service model emphasizing pricing transparency, data visibility, and reduced administrative burden for independent practices facing consolidation and verticalization pressures in U.S. healthcare.

Commercially, BioCareSD generates revenue on a transaction-fee distribution basis, with revenue streams from specialty pharmaceutical distribution and from GPO services delivered through the AllyGPO partnership. Its go-to-market combines enterprise field sales to independent oncology and retina practices, channel partnerships (AllyGPO, WeInfuse), and event-driven demand generation at industry conferences such as the ASRS Business of Retina Conference. Pricing is quote-based and not publicly disclosed. The company is a private subsidiary of BioCare, Inc., a diversified healthcare group that also owns the LogiCare3PL third-party logistics business; no PE, VC, or public ownership signals were identified.

Name

BioCare SD

Legal name

BioCare, Inc.

Website

https://biocaresd.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Specialty Pharmaceutical Distribution

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

340B Program Administration & Contract Pharmacy Services (HLAFALAL), Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK)

Keywords

• Specialty pharmaceutical distribution
• Oncology drug distribution
• Retina drug distribution
• Group purchasing organization services
• Specialty therapy portfolio

Headquarters

HQ city

Tempe

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Pharmaceutical Distribution: BioCareSD generates revenue through distribution of specialty pharmaceutical products to healthcare practices including oncology and retina specialty drugs. The company provides high-touch specialty distribution services with technology-enabled ordering and inventory management.
2. Group Purchasing Organization Services: Through the AllyGPO partnership, BioCareSD participates in GPO services providing specialty drug management and purchasing solutions to independent practices, generating revenue through negotiated pricing arrangements and volume-based distribution.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels3 records

Core offering

BioCareSD is a national specialty pharmaceutical distributor that provides high-touch distribution of specialty biological and pharmaceutical products to independent community-based oncology and retina practices across the United States. The company combines a specialty drug distribution infrastructure with technology integrations (WeInfuse) and a Group Purchasing Organization partnership (AllyGPO) to deliver drug management, pricing transparency, and operational efficiency to healthcare providers. Distribution operations are supported by NABP-accredited facilities in Tempe, AZ and Olive Branch, MS.

Product overview

BioCareSD is a national specialty pharmaceutical distributor and BioCare company offering specialty distribution services and an ever-expanding portfolio of specialty products across multiple disease states. The core offering is specialty distribution infrastructure that integrates with technology platforms like WeInfuse for workflow management. BioCareSD's product portfolio includes Retina Products and Oncology Products, spanning multiple therapy areas to support independent healthcare practices maintain operational efficiency and patient care quality.

Differentiator

Problem solved

Functional benefit

Products and services

• BioCareSD Specialty Distribution Services National specialty pharmaceutical distribution services offering high-touch specialty distribution infrastructure for healthcare providers, with capabilities in drug management, supply reliability, pricing transparency, and distribution across multiple therapy areas. Targeted at independent oncology and retina specialty practices in the United States.
• Retina Products Portfolio Specialty pharmaceutical products and distribution services focused on retina care, supporting independent retina specialty practices with comprehensive product offerings across multiple disease states.
• Oncology Products Portfolio Specialty pharmaceutical products and distribution services focused on oncology care, supporting community oncology practices with comprehensive product offerings across multiple disease states.
• BioCareSD e-Commerce Platform Self-service online ordering and account management platform (store.biocaresd.com) that enables existing BioCareSD healthcare provider customers to place specialty drug orders and manage their accounts.

Quantifiable outcome

• More than tripled retina sites of care in 2025
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature2 records

Partnerships

Three partnerships are on record, tiered strategic and core.

• WeInfusestrategicTechnology or Integration · 22 May 2026BioCareSD partnered with WeInfuse, an infusion management technology platform serving providers across more than 1,300 locations nationwide. The collaboration integrates BioCareSD's specialty therapy portfolio directly into WeInfuse's workflow platform, enabling streamlined ordering, real-time product availability visibility, and improved operational efficiency for infusion centers and pharmacies. This represents BioCareSD's continued investment in technology-enabled distribution capabilities.
• AllyGPOcoreChannel Partner/ Reseller/ Distributor · 20 March 2026BioCareSD has a strategic partnership with AllyGPO, a Group Purchasing Organization, to provide combined specialty GPO and drug distribution services to independent healthcare practices. The partnership offers AI-powered drug management through AllyGPO's AllyIQ technology platform, flexible contracts, and comprehensive product portfolio. The collaboration more than tripled retina sites of care in 2025 and expanded at the ASRS Business of Retina Conference in March 2026, with joint initiatives including the Retina Collective.
• Retina Associates of ClevelandcoreOthers · 16 January 2026Retina Associates of Cleveland, a 50-year-old Ohio-based retina specialty practice, selected AllyGPO for GPO services and BioCareSD for specialty distribution services. The partnership includes access to AllyIQ drug management platform and is designed to help RACI maintain practice independence while improving supply reliability, pricing transparency, and data-driven operational efficiency. This reflects growing demand from community retina practices for alternative GPO and distribution partners.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• McKesson Specialty Health: McKesson is one of the 'Big Three' U.S. pharmaceutical distributors with a dedicated specialty and oncology practice services arm (formerly US Oncology). It directly competes with BioCareSD for oncology and retina specialty drug distribution, but at vastly greater scale, broader product portfolio, and with physician practice management services that BioCareSD does not offer.
• Cencora (formerly AmerisourceBergen): Cencora is one of the largest U.S. pharmaceutical distributors and operates specialty distribution businesses including ION Solutions (community oncology GPO/distributor) and World Courier. It competes with BioCareSD for specialty distribution contracts with independent oncology practices, but with substantially larger scale, manufacturer relationships, and integrated GPO/specialty services.
• Cardinal Health Specialty: Cardinal Health is a 'Big Three' pharmaceutical wholesaler with a dedicated Specialty Solutions business serving oncology, retina, and other specialty practices. It competes directly with BioCareSD in specialty drug distribution to independent practices, while also offering broader medical products and at-home solutions that BioCareSD does not provide.
• Walgreens Specialty Pharmacy (AllianceRx Walgreens): Walgreens operates one of the largest U.S. specialty pharmacy and distribution networks via AllianceRx Walgreens Pharmacy, serving patients and providers across oncology, retina, and other specialty conditions. It overlaps with BioCareSD in specialty drug fulfillment and access, though primarily through retail/specialty pharmacy channels rather than direct practice distribution.

Direct peers

• ION Solutions (Cencora): ION Solutions is a specialty distribution and GPO focused on community oncology practices, owned by Cencora. It is the closest direct competitor to BioCareSD, serving the same independent oncology customer segment with GPO services, drug distribution, and practice support — though at materially larger scale and with Cencora's manufacturer relationships.
• Morris & Dickson: Morris & Dickson is a U.S. specialty pharmaceutical distributor (Top 3 independent wholesaler) that distributes specialty drugs to retail pharmacies, hospitals, and alternate care sites. It competes with BioCareSD in specialty distribution to provider customers and represents a similar mid-sized, privately held, specialty-focused distributor model.
• Shields Health Solutions: Shields Health Solutions partners with health systems and specialty physician practices to build or optimize specialty pharmacies, providing distribution, clinical, and revenue cycle services. It is comparable to BioCareSD in serving specialty practices with distribution-adjacent, high-touch services, particularly in oncology and complex therapeutics.
• CuraScript SD (Express Scripts/Accredo): CuraScript SD is a specialty pharmaceutical distributor serving physician offices, infusion centers, and clinics, owned by Evernorth (Cigna/Express Scripts). It directly competes with BioCareSD in distributing specialty pharmaceuticals to provider sites, with broader payer-integrated reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BiocareSD

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioCare SD